Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.20
+0.82 (4.23%)
May 27, 2026, 12:56 PM EDT - Market open
Denali Therapeutics Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Denali Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $34.36. The average 1-year stock price forecast is 70.10% higher than the current stock price, while the lowest is $20 (-0.99%) and the highest is $42 (+107.92%).
Price Target: $34.36 (+70.10%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Denali Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 17 | 17 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +73.27% | May 26, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 22, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 22, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +98.02% | May 22, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | +53.47% | May 22, 2026 |
Financial Forecast
Revenue This Year
26.25M
Revenue Next Year
147.12M
from 26.25M
Increased by 460.50%
EPS This Year
-2.66
from -2.97
EPS Next Year
-2.48
from -2.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 77.4M | 375.7M | ||||||
| Avg | 26.2M | 147.1M | ||||||
| Low | 5.7M | 34.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,331.3% | ||||||
| Avg | - | 460.5% | ||||||
| Low | - | 30.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.84 | -1.48 | ||||||
| Avg | -2.66 | -2.48 | ||||||
| Low | -3.16 | -2.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.